SMTL ID : 6w8l.1

Crystal structure of JAK1 kinase with compound 10

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.11 Å

Oligo State

monomer

Ligands

1 x R4S: N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropanecarboxamide(Non-covalent)

R4S.1: 24 residues within 4Å: Chain A: L.43, G.44, E.45, G.46, G.49, K.50, V.51, A.68, K.70, V.100, M.118, E.119, F.120, L.121, P.122, S.123, G.124, S.125, E.128, R.169, N.170, L.172, G.182, D.183 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:D.183 Hydrogen bonds: A:L.121, A:L.121, A:S.125, A:D.183, A:D.183

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fensome, A. et al., Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1. Bioorg.Med.Chem. (2020)

Release Date

2020-04-08

Peptides

Tyrosine-protein kinase JAK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK1

Related Entries With Identical Sequence